Incyte and Edison Scientific Announce Strategic Collaboration to Employ the Kosmos AI Platform for Research and Development
Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association 2026 Congress
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® Cream in Adults with Moderate Atopic Dermatitis
Incyte Announces FDA Approval of Jakafi XR Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease
Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology Annual Meeting
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody in Patients with Microsatellite Stable Colorectal Cancer
Oreterra Receives Conditional Approval to Sell Option to Buy Down Newmont Lake Royalty to Enduro Metals
Harvest Gold Announces Non-Brokered Private Placement To Fund 2026 Drill Program On Its Flagship Mosseau Property
